CM-363

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameCM-363
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSTAT5 transcription factor inhibitorsSignal transducer and activator of transcription 3 inhibitors
TargetsSTAT5 transcription factorSignal transducer and activator of transcription 3
Therapy Area/IndicationsBreast NeoplasmsLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentro Atlántico del Medicamento Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentro Atlántico del Medicamento Sa
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsLeukemia, Myelogenous, Chronic

Other Information

ATC CodeN/A
Related LinksN/A